Quarterly report pursuant to Section 13 or 15(d)

Stock Plans

v3.24.4
Stock Plans
 9 Months Ended
Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]  
Stock Plans

 

2. Stock Plans

 

The following table summarizes option activity:

 

Schedule of our option activity                                
    Options
(in thousands)		     Weighted
Average
Exercise
Price
per share		     Weighted
Average
Remaining
Option Term
(in years)		     Aggregate
Intrinsic
Value
(in thousands)		  
Outstanding at December 31, 2023     93     $ 73.46       8.35     $ -  
Outstanding at September 30, 2024     93       71.75       7.29       -  
Exercisable at September 30, 2024     93       71.75       7.29       -  

 

The following table summarizes the stock-based compensation expense recorded for awards under our stock option plans:

 

Schedule of the stock-based compensation expense                                
    Three Months Ended     Nine Months Ended  
    September 30,     September 30,  
(in thousands of U.S. dollars)   2024     2023     2024     2023  
Research and development   $ -     $ 52     $ -     $ 106  
Selling, general and administrative     -       359       -       859  
Total stock-based compensation   $ -      $ 411     $ -     $ 965  

 

We use the Black-Scholes-Merton option-pricing model to estimate the fair value of our stock options. There were no options granted or shares awarded during the nine months ended September 30, 2024 and 2023.

 

As of September 30, 2024, there was no unrecognized compensation expense related to non-vested stock options.